Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole MR for erosive esophagitis
CTR20160226Phase 3Active
- Sponsor
- Hengrui Therapeutics
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexlansoprazole in erosive esophagitis (EE), sponsored by Hengrui Therapeutics. Started Apr 2016; status: active.
02
Drugs
dexlansoprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20160226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160226.